Latest news with #NationalHealthRegulatoryAuthority
Biz Bahrain
26-04-2025
- Health
- Biz Bahrain
Empowering Women's Health: Bahrain International Women's Health Conference Kicks Off
The second edition of the Bahrain International Women's Health Conference, organised by BDA for Conference and Exhibition, officially launched, drawing the participation of an esteemed group of international and local speakers, alongside healthcare professionals, specialists, and stakeholders from across the globe. Attendees represent a diverse array of countries, including Bahrain, Egypt, Jordan, Saudi Arabia, and the United Arab Emirates, as well as European nations such as the United Kingdom and Ukraine. The opening day featured a dedicated public forum exclusively for a female audience. This complimentary, hour-long session brought together prominent speakers and influential women figures to address a range of topics central to women's well-being. The discussion focused on health education, empowerment, and motivational insights, aiming to inspire positive lifestyle choices and foster a supportive environment for women of all ages. The conference will continue with a robust scientific agenda comprising expert-led panel discussions and interactive workshops that address the latest advancements in women's health. The programme has been officially accredited by the National Health Regulatory Authority (NHRA), with 16 Continuing Medical Education (CME) hours approved, underscoring the event's scientific and professional merit. This year's edition builds on the notable success of the inaugural conference, which garnered strong attendance and meaningful engagement from researchers and practitioners within the women's health sector. The 2024 event was widely commended for its role in drawing attention to the critical importance of women's health, fostering collaborative dialogue, and facilitating cross-border knowledge exchange. Encouraged by this positive momentum, the organisers have expanded the scope of the 2025 edition, offering a more comprehensive and diverse platform to address emerging challenges and opportunities in the field.
Daily Tribune
10-03-2025
- Health
- Daily Tribune
Private hospital and doctor fined BD60,000 after birth error leaves baby disabled
A private hospital and doctor have been ordered to pay BD60,000 after a delivery went horribly wrong, leaving a baby permanently disabled. The High Civil Appeals Court confirmed the ruling following a review of medical negligence during the boy's birth, which caused severe brain injuries and a lifelong disability rated at 90 per cent. Lawyer Jassim Sarhan, acting for the family, told the court the mother had checked into the hospital for routine childbirth. Problems But problems arose quickly, and although a Caesarean was clearly required, the doctor chose instead to use a suction device to deliver the baby. That decision had terrible consequences: the newborn did not cry at birth, suffered oxygen loss, brain damage, and slow heartbeat, forcing medical staff to urgently transfer him to Salmaniya Medical Complex. He remained in intensive care there for 40 days, leaving him permanently impaired, unable to care for himself, and needing round-the-clock supervision. Medical steps Earlier, the court had tasked experts from the National Health Regulatory Authority (NHRA) to investigate exactly what happened and whether proper medical steps were followed. NHRA experts found the doctor had made clear errors. They revealed the doctor had failed to check the baby's heartbeat for a full hour during the labour, something considered unacceptable by medical guidelines. Risks The doctor also neglected to explain the risks involved with suction delivery to the parents, misused the device itself, and failed to take a blood sample from the umbilical cord immediately after birth despite obvious distress signs. In its original ruling, the lower court had instructed the hospital and the doctor to jointly pay BD50,000 to the father as guardian of the child, plus another BD20,000 to both parents for their emotional suffering, along with court fees and lawyers' costs. However, the hospital and doctor appealed the decision, and the High Civil Appeals Court decided to trim down the emotional damages paid to the parents from BD20,000 to BD10,000, while keeping intact the BD50,000 for the child's injuries.
Bahrain News Gazette
17-02-2025
- Health
- Bahrain News Gazette
Crown Prince of Bahrain Visits First Successful Sickle Cell Treatment Patient Outside US
Manama: His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister of Bahrain, visited the world's first sickle cell disease patient outside the United States to successfully complete treatment with Casgevy, a CRISPR-based gene-editing therapy. The treatment was administered at the Bone Marrow and Stem Cell Transplant Unit at the Royal Medical Services – Bahrain Oncology Center. According to Bahrain News Agency, HRH Prince Salman bin Hamad emphasized the Kingdom's dedication to integrating scientific advancements into treatment and rehabilitation services. This commitment aligns with the broader vision of His Majesty King Hamad bin Isa Al Khalifa to enhance citizens' health and wellbeing and strengthen the Kingdom's health sector. HRH Prince Salman bin Hamad reiterated Bahrain's commitment to advancing its health sector by delivering world-class healthcare and medical treatments. He highlighted the significance of forging partnerships with international health institutions to ensure access to cutting-edge medical technologies. During the visit, His Royal Highness congratulated the patient on the successful completion of the treatment and inquired about his health and well-being. He was accompanied by several senior officials. Under the directives of HRH the Crown Prince and Prime Minister, the National Health Regulatory Authority approved the treatment 'CASGEVY (Exa-cel)' for patients with sickle cell anaemia and beta-thalassemia. This approval followed a thorough evaluation of clinical trials and submitted data, positioning Bahrain as the first country in the region and the second globally to authorize the use of this treatment. The Royal Medical Services – Bahrain Oncology Center has achieved a historic milestone by completing the treatment of a sickle cell disease patient using Casgevy for bone marrow transplantation. This accomplishment marks the first successful treatment of its kind outside the United States, strengthening Bahrain's status as a leader in precision medicine and innovative healthcare solutions.
Daily Tribune
16-02-2025
- Health
- Daily Tribune
Bahrain Achieves Historic Medical Milestone in Bone Marrow Transplantation
In alignment with the directives of His Majesty the King and under the guidance of the Crown Prince and Prime Minister, Bahrain has prioritized the advancement of treatment options for patients with chronic and hereditary blood disorders. In a significant step forward, the National Health Regulatory Authority (NHRA) has approved the use of "CASGEVY (Exa-cel)" for the treatment of sickle cell anemia and beta-thalassemia. This approval follows a rigorous evaluation process, including an extensive review of clinical trials and manufacturer-submitted data, positioning Bahrain as the first country in the region and the second worldwide to approve this innovative therapy. Furthermore, the Royal Medical Services - Bahrain Oncology Center has achieved a historic medical breakthrough by successfully completing the treatment of a sickle cell anemia patient through bone marrow transplantation utilizing the CRISPR gene-editing technique. This accomplishment establishes Bahrain as a global leader in advanced medical treatments, demonstrating its commitment to pioneering healthcare solutions and enhancing the quality of life for its citizens.
